Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,633.96% | -7.16% | 64.33% | -- | -- |
| Total Depreciation and Amortization | -4.05% | 4.66% | 10.92% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,255.77% | 492.05% | -86.98% | -- | -- |
| Change in Net Operating Assets | 234.46% | -911.48% | 218.26% | -- | -- |
| Cash from Operations | -1,117.27% | -1,145.53% | 85.96% | -127.57% | -24.61% |
| Capital Expenditure | -26.05% | 12.22% | 42.85% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | 1,180.00% | -28.57% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 131.96% | 34.29% | 169.19% | -- | -- |
| Cash from Investing | -91.64% | 40.54% | 413.25% | 131.44% | 25.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 364.29% | -76.67% | 36.36% | -- | -- |
| Repurchase of Common Stock | -60.90% | 73.27% | -9.90% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.17% | 73.22% | -9.60% | -429.96% | 39.49% |
| Foreign Exchange rate Adjustments | -507.95% | 19.84% | 215.60% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -251.45% | 53.54% | 1,011.94% | 74.73% | 28.20% |